aVaxziPen
Abingdon · Founded 2017
About aVaxziPen
aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Last round: Undisclosed (Jun 2023)
- Website: https://www.avaxzipen.com/
- Phone: +44 (0) 1235 577 120
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/avaxzipen-114552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.